PYRALEROSIS 10 MG 10 EXT. REL.F.C.TABS

Pharmacology Nonspecific potassium channel blocker which improves conduction in focally demyelinated axons by delaying repolarization and prolonging the duration of action potentials. Enhanced neuronal conduction is thought to strengthen skeletal muscle fiber twitch activity thereby improving peripheral motor neurologic function. Indications Treatment to improve walking in patients with multiple sclerosis (MS) Dosing: Adult Multiple sclerosis: Oral: 10 mg every 12 hours (maximum daily dose: 20 mg); no additional benefit seen with doses >20 mg daily